Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (15 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net sales
735
811
875
949
984
980
972
Cost of sales
558
603
645
689
693
691
691
Gross Profit
177
208
229
260
290
290
281
Selling, general and administrative expenses
147
159
164
187
201
194
206
Litigation charge
0
0
0
0
0
11
0
Restructuring and integration (income) expenses
7
4
1
1
3
1
0
Other income, net
-6
2
1
1
1
1
1
Operating Income
18
47
65
71
87
85
76
Other non-operating income, net
4
0
3
-1
0
-2
0
Interest expense
9
7
4
3
2
2
2
Earnings from Continuing Operations Before Taxes
12
40
64
68
85
82
74
Provision for income taxes
6
15
0
25
32
29
26
Earnings from continuing operations
6
25
64
43
53
53
48
Loss from discontinued operations, net of income tax benefit of $1,401, $6,580 and $1,062
-2
-3
-2
-2
-2
-10
-2
Net earnings
3
22
62
41
51
43
46
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (34 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
12
11
13
6
14
19
Accounts receivable, less allowances
n/a
105
104
99
125
127
124
Amount after valuation and FIFO reserves
n/a
241
248
267
269
278
286
Deferred income taxes
n/a
18
32
33
36
37
41
Assets held for sale
n/a
0
0
0
0
0
0
Prepaid expenses and other current assets
n/a
8
6
6
10
11
11
Total current assets
n/a
385
401
419
446
466
480
Property, plant and equipment, net
n/a
61
64
64
64
65
69
Goodwill
n/a
1
26
36
38
55
55
Other intangibles, net
n/a
11
32
37
35
34
29
Deferred incomes taxes
n/a
21
17
11
10
15
11
Other assets
n/a
14
11
10
23
39
37
Total assets
n/a
493
551
577
616
674
681
Liabilities and owners' equity
Notes payable
n/a
53 52887000
73 73000000
40 40453000
21 21406000
57 56558000
47 47427000
Current portion of long-term debt
n/a
12 12402000
0 109000
0 120000
0 59000
0 175000
0 16000
Accounts payable
n/a
50 49919000
51 50880000
62 62283000
71 71469000
71 70674000
73 72711000
Sundry payables and accrued expenses
n/a
29 29280000
33 33409000
42 41723000
42 41939000
49 49412000
41 40706000
Accrued Customer Returns
n/a
23 23207000
25 25074000
29 29033000
31 31464000
31 30621000
39 38812000
Accrued Rebates
n/a
24 23668000
22 22373000
27 27349000
29 28758000
26 26076000
27 27196000
Payroll and commissions
n/a
23 23468000
24 24036000
21 21211000
25 25221000
17 17313000
17 17048000
Total current liabilities
n/a
215 214831000
229 228881000
222 222172000
220 220316000
251 250829000
244 243916000
Long-term debt
n/a
0 307000
0 190000
0 75000
0 16000
0 83000
0 62000
Accrued postretirement benefits
n/a
21 21044000
0 0
0 0
0 0
0 0
0 0
Other accrued liabilities
n/a
22 21944000
24 23557000
22 21650000
22 21840000
15 15024000
13 12922000
Accrued asbestos liabilities
n/a
25 24792000
26 26141000
25 25110000
24 23919000
33 33462000
32 32185000
Total liabilities
n/a
283 282918000
279 278769000
269 269007000
266 266091000
299 299398000
289 289085000
Commitments and contingencies
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Common stock
n/a
48 47872000
48 47872000
48 47872000
48 47872000
48 47872000
48 47872000
Capital in excess of par value
n/a
77 77471000
80 79789000
82 82348000
88 87563000
91 91411000
93 93247000
Retained earnings
n/a
98 97535000
154 153555000
187 186693000
228 228036000
259 259160000
291 291481000
Accumulated other comprehensive income
n/a
1 716000
3 3299000
4 3879000
2 1786000
-3 -2652000
-6 -6474000
Treasury stock - at cost
n/a
-14 -13711000
-13 -12562000
-13 -13205000
-16 -15825000
-22 -21638000
-34 -34147000
Balance
n/a
210 209883000
272 271953000
308 307587000
349 349432000
374 374153000
392 391979000
Total liabilities and stockholders' equity
n/a
493 492801000
551 550722000
577 576594000
616 615523000
674 673551000
681 681064000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Mar 8, 2013 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (50 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net earnings
3
22
62
41
51
43
46
Depreciation and amortization
14
14
14
16
18
17
18
Amortization of deferred financing cost
0
0
1
1
1
1
1
Increase (decrease) to allowance for doubtful accounts
1
1
0
-1
1
0
3
Increase to inventory reserves
6
7
5
5
5
4
2
Loss from sale of European distribution business
7
0
0
0
0
0
0
Amortization of deferred gain on sale of buildings
-1
-1
-1
-1
-1
-1
-1
Gain on disposal of property, plant and equipment
0
-1
0
0
0
0
0
Gain on repurchase of convertible debentures
0
0
0
0
0
0
0
Gain on sale of investment
-2
0
0
0
0
0
0
Equity income from joint ventures
0
0
-3
0
0
1
-1
Employee Stock Ownership Plan allocation
0
2
3
4
4
2
2
Stock-based compensation expense
1
1
2
2
4
5
5
Excess tax benefits related to the exercise of employee stock grants
0
0
-1
0
-1
-1
-1
(Increase) decrease in deferred income taxes
-2
9
9
6
-1
-5
-1
Decrease in unrecognized tax benefit
0
-1
0
0
0
0
0
Increase (decrease) in tax valuation allowance
3
0
-22
-1
0
0
0
Loss from discontinued operations, net of income tax benefit of $1,401, $6,580 and $1,062
2
3
2
2
2
10
2
(Increase) decrease in accounts receivable
41
19
10
15
-27
2
-2
Increase in inventories
30
-48
3
-2
-6
-7
-13
(Increase) decrease in prepaid expenses and other current assets
3
-1
1
-1
-4
-1
0
Increase (Decrease) in Accounts Payable
-13
-2
-3
3
12
-4
2
Increase (decrease) in sundry payables and accrued expenses
14
8
4
7
9
-8
2
Net changes in other assets and liabilities
-5
-3
-10
-5
-8
-9
1
Net cash provided by operating activities
102
28
75
94
58
47
65
Proceeds from the sale of property, plant and equipment
0
0
0
0
0
0
0
Net cash received from the sale of land and buildings
0
3
0
0
0
0
0
Acquisitions of and investments in businesses
-13
-2
-71
-39
-13
-38
0
Divestiture of European distribution business
1
0
1
0
0
0
0
Divestiture of joint ventures
4
2
4
0
0
0
0
Proceeds from Sale of Preferred Stock Investment
4
0
0
0
0
0
0
Capital expenditures
-7
-11
-11
-12
-11
-14
-18
Other investing activities
0
0
0
0
-1
0
0
Net cash used in investing activities
-11
-8
-76
-50
-25
-51
-18
Net borrowings (repayments) under line-of-credit agreements
-88
-6
20
-33
-19
35
-9
Issuance of common stock
28
0
0
0
0
0
0
Issuance of unsecured promissory notes
5
0
0
0
0
0
0
Net borrowings (payments) of long-term debt and capital lease obligations
-32
-5
-12
0
0
0
0
Purchase of treasury stock
0
0
-4
-5
-7
-10
-20
Repurchase of convertible debentures
0
0
0
0
0
0
0
Increase (decrease) in overdraft balances
0
-3
1
2
-3
1
1
Payments of Debt Issuance Costs
-4
-1
0
0
-1
0
-1
Proceeds from exercise of employee stock options
0
0
3
0
0
0
0
Excess tax benefits related to the exercise of employee stock grants
0
0
1
0
1
1
1
Adjustment to costs related to issuance of common stock
0
0
0
0
0
0
0
Dividends paid
0
-5
-6
-8
-10
-12
-14
Net cash provided by (used in) financing activities
-91
-19
1
-43
-39
15
-41
Effect of exchange rate changes on cash
4
1
-1
1
-1
-3
-1
Net increase (decrease) in cash and cash equivalents
4
2
-1
2
-8
8
5
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Feb 27, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo